Contraception, unintended pregnancy, and induced abortion within 24 months of delivery in China: a retrospective cohort study.


Journal

Contraception
ISSN: 1879-0518
Titre abrégé: Contraception
Pays: United States
ID NLM: 0234361

Informations de publication

Date de publication:
03 2021
Historique:
received: 26 08 2020
revised: 06 12 2020
accepted: 21 12 2020
pubmed: 31 12 2020
medline: 16 10 2021
entrez: 30 12 2020
Statut: ppublish

Résumé

To explore the prevalence of contraceptive use, unintended pregnancy, and induced abortions within 24 months postpartum in eastern, central, and western regions of China and in China overall. We conducted a retrospective cohort study and selected women who delivered a live birth between 12 and 24 months before the survey at 60 hospitals in eastern, central, and western regions of China. We used structured questionnaires for data collection and applied life-table analyses to estimate the prevalence of contraception, unintended pregnancy, and abortions. We used clustered log-rank tests to compare trends and rate differences at each time interval between/among regions. A total of 19,939 postpartum women were contacted, and 18,045 (90.5%) of them agreed to be interviewed. The 6-, 12-, and 24-month rates for modern contraceptive methods were 62.7% (95% confidence interval [CI] 58.9-66.4), 72.4% (95% CI 68.8-75.7), and 73.2% (95% CI 69.6-76.6), respectively. Condoms accounted for 79% of contraceptive initiators. The 6-, 12-, and 24-month rates were 1.4% (95% CI 1.2-1.7), 5.3% (95% CI 4.5--6.1), and 13.1% (95% CI 11.3-14.8) for unintended pregnancy; and 1.1% (95% CI 0.8-1.3), 4.0% (95% CI 3.4-4.6), and 10.4% (95% CI 8.9-11.8) for induced abortion, respectively. By 24 months postpartum, 3-quarters of unintended pregnancies ended in abortion. The 24-month rates of modern contraceptive methods (75.2% vs73.4%, 71.1%), unintended pregnancy (15.3% vs 11.1%, 12.6%), and induced abortion (11.8% vs 9.9%, 9.4%) were higher in the western region relative to the eastern or central regions. Postpartum contraception use was relatively high in China but dominated by less-effective methods, and these may contribute to higher risks of unintended pregnancy and induced abortion during the postpartum period. Use of long-acting reversible contraceptives and effective and reliable short-acting methods should thus be fostered in postpartum family planning services in China. A national postpartum family planning program is needed in China. Service providers should work on counselling postpartum women and their partners with respect to long-acting reversible contraceptive methods, and to effectively and reliably use short-acting methods during the postpartum period.

Identifiants

pubmed: 33378645
pii: S0010-7824(20)30467-4
doi: 10.1016/j.contraception.2020.12.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

144-150

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Yan Che (Y)

NHC Key Lab. of Reproduction Regulation(Shanghai Institute of Planned Parenthood Research), School of Public Health, Fudan University, Shanghai, China. Electronic address: yan.che@sippr.org.cn.

Yuyan Li (Y)

NHC Key Lab. of Reproduction Regulation(Shanghai Institute of Planned Parenthood Research), School of Public Health, Fudan University, Shanghai, China.

Xiangying Gu (X)

Tianjin Medical University General Hospital, Tianjin, China.

Lifang Jiang (L)

Henan Key Laboratory of Population Defects Prevention, Henan Provincial Research Institute for Population and Family Planning, Zhengzhou, China; National Health Commission Key Laboratory of Birth Defects Prevention, Zhengzhou, China.

Yuanzhong Zhou (Y)

School of Public Health, Zunyi Medical University, Zunyi, China.

Xiaoyu Hu (X)

Shanghai Women's and Children Health Center, Shanghai, China.

Li Jiang (L)

Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

Tongyin Cheng (T)

Xinjiang Urumqi Maternal and Child Health Hospital, Urumqi, China.

Xiaojing Dong (X)

The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Xiaochen Huang (X)

Fujian Maternity and Children Health Hospital, Fuzhou, China.

Yongfeng Luo (Y)

Jilin Guojian Maternity Hospital, Changchun, China.

Wen Lv (W)

Tongde Hospital of Zhejiang Province, Hangzhou, China.

Guangli Qiao (G)

Health and Reproductive Health Technical Guidance Service Center of Ningxia Hui Autonomous Region, Yinchuan, China.

Jiandong Song (J)

Affiliated Hospital of Inner Mongolia Medical University, Huhehaote, China.

Wei Xia (W)

Institute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Linai Zhang (L)

Shanxi Maternal and Child Health Hospital, Taiyuan, China.

Yanfei Zhou (Y)

Changsha Hospital for Maternal and Child Health Care, Changsha, China.

Yan Zhang (Y)

NHC Key Lab. of Reproduction Regulation(Shanghai Institute of Planned Parenthood Research), School of Public Health, Fudan University, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH